These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 15756146)

  • 1. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
    Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].
    Gutkowski K; Gutkowska D; Bilkiewicz T
    Przegl Lek; 2007; 64(3):148-52. PubMed ID: 17941466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon alpha and its contribution to autoimmunity.
    Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME
    Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune hepatitis and/or hepatitis C].
    Simonović J; Dokić Lj; Svirtlih N; Djordjević M; Bozić N; Poluga J
    Srp Arh Celok Lek; 1999; 127(3-4):109-13. PubMed ID: 10500434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of autoimmune and extra-hepatic manifestations of HCV infection.
    Lunel F; Cacoub P
    Ann Med Interne (Paris); 2000 Feb; 151(1):58-64. PubMed ID: 10761564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C].
    Heller J; Musiolik J; Homrighausen A; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 1996 Sep; 121(39):1179-83. PubMed ID: 8925742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndromes and complications of interferon therapy.
    Borg FA; Isenberg DA
    Curr Opin Rheumatol; 2007 Jan; 19(1):61-6. PubMed ID: 17143098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of thyroid autoantibodies in the development of thyroid dysfunction in Taiwanese chronic hepatitis C patients with interferon-alpha and ribavirin combination therapy.
    Huang JF; Chuang WL; Dai CY; Chen SC; Lin ZY; Lee LP; Lee PL; Wang LY; Hsieh MY; Chang WY; Yu ML
    J Viral Hepat; 2006 Jun; 13(6):396-401. PubMed ID: 16842442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmunity induced by interferon-alpha therapy for chronic viral hepatitis.
    Dumoulin FL; Leifeld L; Sauerbruch T; Spengler U
    Biomed Pharmacother; 1999 Jun; 53(5-6):242-54. PubMed ID: 10424246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Syndrome of overlap: Chronic hepatitis C/autoimmune hepatitis: fact or fancy?].
    Antonaci S; Giannelli G; Simone B; Vella FS
    Recenti Prog Med; 2005 Jan; 96(1):27-31. PubMed ID: 15789635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
    Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
    J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyspecificity of antimicrosomal thyroid antibodies in hepatitis C virus-related infection.
    Peoc'h K; Dubel L; Chazouillères O; Ocwieja T; Duron F; Poupon R; Johanet C
    Am J Gastroenterol; 2001 Oct; 96(10):2978-83. PubMed ID: 11693336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.
    Gatselis NK; Georgiadou SP; Koukoulis GK; Tassopoulos N; Zachou K; Liaskos C; Hatzakis A; Dalekos GN
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1563-73. PubMed ID: 17094775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extrahepatic manifestations of hepatitis C virus infection].
    Loustaud-Ratti V; Lunel F
    Rev Prat; 2000 May; 50(10):1089-93. PubMed ID: 10905094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
    Ettinger OA; Nikitin IG; Storozhakov GI
    Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
    [No Abstract]   [Full Text] [Related]  

  • 18. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study.
    Ganne-Carrie N; Medini A; Coderc E; Seror O; Christidis C; Grimbert S; Trinchet JC; Beaugrand M
    J Autoimmun; 2000 Mar; 14(2):189-93. PubMed ID: 10677250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic hepatitis C/autoimmune hepatitis overlap syndrome: report of two cases].
    Vella FS; Simone B; Orlando P; Simone O; Antonaci S
    Recenti Prog Med; 2004 Oct; 95(10):472-5. PubMed ID: 15560294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
    Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.